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Received 31 August 2010; received in revised form 28 September 2010; accepted 28 September 2010Abstract Use of stem cells, whether adult or embryonic for clinical applications to treat diseases such as Parkinson's, macular
degeneration or Type I diabetes will require a homogenous population of mature, terminally differentiated cells. A current area of
intense interest is the development of defined surfaces for stem cell derivation, maintenance, proliferation and subsequent
differentiation, which are capable of replicating the complex cellular environment existing in vivo. During development many
cellular cues result from integrin signalling induced by the local extracellular matrix. There are 24 known integrin heterodimers
comprised of one of 18 α subunits and one of 8 β subunits and these have a diverse range of functions mediating cell-cell adhesion,
growth factor receptor responses and intracellular signalling cascades for cellmigration, differentiation, survival and proliferation.
Wediscuss herea brief summary of defined conditions for humanembryonic stemcell culture togetherwith a description of integrin
function and signalling pathways. The importance of integrin expression during development is highlighted as critical for lineage
specific cell function and how consideration of the integrin expression profile should be made while differentiating stem cells for
use in therapy. In addition this review summarises the known integrin expression profiles for human embryonic stem cells and 3
common adult stem cell types: mesenchymal, haematopoietic and neural. We then outline some of the possible technologies
available for investigating cell-extracellular matrix interactions and subsequent integrin mediated cell responses.
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Human embryonic stem cells (hESC) were first derived in
1998 (Thomson et al., 1998) and in the short period since
are beginning to realise their potential as a reproducible
source of cells for clinical applications. In July this year,
the United States Food and Drug Administration gave
approval to Geron Corporation for a Phase I clinical trial
to use hESCs for treatment of acute spinal cord injury
(Briefing, 2010).
HESC culture and derivation conditions have trended
toward the development of a fully defined, animal protein
free system suitable for generating hESC or their functional
differentiated progeny for clinical applications. Consider-
able research efforts have led to the identification of key
signalling pathways for hESC maintenance such as the
transforming growth factor-β superfamily [Activin, nodal,
bone morphogenetic proteins, growth differentiation factors
(Hannan et al., 2009; James et al., 2005; Vallier et al.,
2005)], growth factors that activate receptor tyrosine
kinases (e.g. mitogen activated protein kinase kinase [MEK]
and extracellular signal-regulated kinase [ERK]) such as basic
fibroblast growth factor (bFGF) and platelet derived growth
factor (Amit et al., 2000; Pebay et al., 2005; Li et al., 2007;
Kang et al., 2005), the insulin –like growth factor (IGF) and
Wnt pathways (Sato et al., 2004).
As well as identifying soluble maintenance factors, there
has been a large focus on the composition of the extracel-
lular matrix (ECM) required for hESC growth (Xu et al., 2001;
Amit et al., 2004; Evseenko et al., 2008). This has led to
discovery of a number of ECM molecules or domains thereof
capable of assisting in the maintenance of undifferentiated
hESC alone or in combination, including laminin 511
(Miyazaki et al., 2008; Rodin et al., 2010), fibronectin and
vitronectin (Braam et al., 2008; Rowland et al., 2009; Prowse
et al., 2010; Melkoumian et al., 2010). However, little
investigation into why or how each of these ECM molecules
assists in maintaining hESCs has so far been conducted. ECM
molecules such as the ones listed above are bound by cell
surface proteins known as integrins. Evidence exists that
removal of hESCs from their ECM substrate and passaging by
dissociation into single cells is detrimental to their survival
and differentiation capacity (Ungrin et al., 2008; Pera and
Tam, 2010) initiating signalling cascades for anoikis (Wang
et al., 2009). However, addition of inhibitors of the Rho-
associated kinase (ROCK) signalling pathway can be used to
improve survivability (Watanabe et al., 2007) but in single
cell suspensions only a 58% survival rate is observed (Steineret al., 2010). For hESC up-scale for therapeutic applications
these methods are not a viable option. More recently, large
scale screens of small molecule libraries have identified
compounds that improve hESC survival, the actions of which
have been linked to cell-cell and cell-ECM interactions
through cell surface molecules such as integrins and
cadherins that block ROCK pathways (Xu et al., 2010).
Specifically, the MEK-ERK signalling cascade has been shown
to be activated in hESC to promote self-renewal and
survivability (Armstrong et al., 2006; Brill et al., 2009)
both by extracellular growth factor addition (Li et al., 2007;
Kang et al., 2005) and through activation of cell surface
integrins (Xu et al., 2010). Examples in the literature have
demonstrated the changing ECM and integrin profile of hESC
as they differentiate (Wong et al., 2010; van Laake et al.,
2010) although it appears the changes may be independent
of growth conditions for undifferentiated cells (Braam et al.,
2008). This indicates that in order to generate mature,
functional and viable differentiated progeny from hESC for
clinical applications the pathways by which ECM molecules
signal to the cells needs to be better understood in addition
to those already investigated for soluble maintenance
factors [for review see (Pera and Tam, 2010)]. Furthermore,
ECM receptors such as integrins can activate nearby growth
factor receptors such as fibroblast growth factor receptor,
epidermal growth factor receptor 1, insulin-like growth
factor receptor and subsequent downstream survival path-
ways such as mitogen activated protein kinase and ERK
(Comoglio et al., 2003). In this review we discuss the basics
of cell surface integrin expression and examine the changes
and importance of integrins during development using the
mouse as a model. We then compare integrin expression
profiles from hESC and other human adult stem cell types and
conclude by reviewing studies that have used defined
surfaces and high throughput technologies that could be
used in order to better understand hESC-ECM interactions
and integrin mediated signals. Due to length constraints on
the review article the authors apologise for not highlighting
all relevant references.
Integrins
Integrins are a large family of receptors which can bind ECM
components, soluble extracellular ligands or other membrane
bound cell surfacemolecules. Inmammals, there are 24 known
heterodimeric integrin receptors comprising of a non-covalent
pairing of one of 8 β subunits with one of 18 α subunits. The
different heterodimers eachhave specific ECMbindingpartners
Table 1 Integrin subunits, ECM binding partners and the phenotype of knockout mice
Subunits Ligands Phenotype post mutation or knockouta
β1 Failure to implant and ICM deficiencies
(Stephens et al., 1995; Fassler and Meyer, 1995).
α1 Laminins, collagens Retinal degeneration (Peng et al., 2008).
α2 Laminins, collagens Diminished mammary gland branching
(Chen et al., 2002), delayed platelet aggregation
(Verkleij et al., 1998).
α3 Laminins, collagens, fibronectin, entactin Defective neuron migration (Anton et al., 1999),
lung and kidney defects (Kreidberg et al., 1996).
α4 Fibronectin, VCAM-1 Embryonic lethality d12.5 due to placental and
cardiac defects (Yang et al., 1995).
α5 Fibronectin Embryonic lethality d9 (Yang et al., 1993).
α6 Laminins Skin blistering and lethality post-birth
(Georges-Labouesse et al., 1996).
α7 Laminins Placental defects (Welser et al., 2007).
α8 Fibronectin, vitronectin, tenascin Reduced kidney mass (Hartner et al., 2002).
α9 Fibronectin, vitronectin, tenascin Defects in lymph system (Bazigou et al., 2009).
α10 Collagens Dysfunction of chondrocytes leading to bone
defects (Bengtsson et al., 2005).
α11 Collagens Dwarfism and incisor defects (Popova et al., 2007)
αV Fibronectin, vitronectin Impaired cerebral blood vessel development
(McCarty et al., 2005).
β2
αL ICAM-1, ICAM-2, ICAM-3 Impaired leukocyte recruitment (Schmits et al., 1996).
αM iC3b, coagulation factor X, ICAM-1, fibrinogen Impaired mast cell development (Rosenkranz et al.,
1998).
αX iC3b, fibrinogen Unreported
αD ICAM-3 Unreported
β3 Impaired platelet aggregation and clot formation
(Law et al., 1999).
αIIB Fibronectin, fibrinogen, von Willebrand factor,
thrombospondin, tenascin, vitronectin
Reduced platelet aggregation (Tronik-Le Roux et al.,
2000).
αV Fibronectin, fibrinogen, von Willebrand factor,
thrombospondin, vitronectin, osteopontin, collagens
β4 Skin blistering and lethality post-birth
(van der Neut et al., 1996).
α6 Laminins
β5 No defects discernable (Huang et al., 2000).
αV Fibronectin, vitronectin
β6 Lung defects (Huang et al., 1996; Munger et al., 1999).
αV Fibronectin, tenascin
β7 Impaired lymphocyte migration and homing
(Wagner et al., 1998; Kunkel et al., 1998).
α4 Fibronectin, VCAM-1, MAdCAM-1
αE E-cadherin Reduced numbers of lymphocytes (Schon et al., 1999).
β8 Defects in vascular morphogenesis (Zhu et al., 2002)
αV Vitronectin
This table was adapted from (Docheva et al., 2007) and (Hynes, 2002). The phenotypes listed here for each integrin knockout are to
highlight the diverse range of phenotypes observed and do not necessarily reflect the dominant phenotype. a More defects/integrin
subunit in mouse models are highlighted in (Hynes, 2002) and (Bouvard et al., 2001).
3Stem cell integrins: Implications for ex-vivo culture and cellular therapies(Table 1) and have been reviewed in detail previously (Berrier
and Yamada, 2007; Luo et al., 2007; Humphries et al., 2006;
Hynes, 2002). Each subunit has a large extracellular domain
and short cytoplasmic fragment (50aa,with theexception ofβ4
which is about 1000aa) forming a typical type I transmembrane
glycoprotein (Hynes, 2002). Some integrin subunits such as β1
are ubiquitously expressed whereas others are expressed in
specific tissues or stages of differentiation. For example, β7 isspecific to subsets of leukocytes (Humphries et al., 2006;
Pribila et al., 2004) and is involved in trafficking of leukocytes
to sites of injury or inflammation. Cell surface integrins play a
major role in communication between the cytoplasm and
extracellular space. Integrins control a whole host of cellular
functions through inside-out and outside-in signalling including
cell motility, survival, differentiation and proliferation
(through interaction with members of the Cyclin family
Figure 1 Integrin Functions. Illustration of general integrin functions in cell-cell adhesion, cell-ECM adhesion and integrin-growth
factor cross-talk. ECM, extracellular matrix; GF, growth factor; GFR, growth factor receptor; VCAM, vascular cell adhesion molecule
(an example of many integrin mediated cell-cell adhesions).
4 A.B.J. Prowse et al.(Docheva et al., 2007)) as well as ECM remodelling (Berrier and
Yamada, 2007) and embryonic development (Hynes, 2002;
Bouvard et al., 2001) (Fig. 2).
The extracellular domain of integrins can bind ECM proteins
used in hESC support such as collagen, fibronectin, laminin and
vitronectin as well as members of the SIBLING family (Small
Integrin Binding Ligand, N-Linked Glycoproteins e.g. osteo-
pontin and bone sialoprotein). Integrins can also associatewith
receptors on the surface of other cells through directFigure 2 Outside-In Integrin Signalling Pathways. Integrin
signalling pathways affecting cell fate. Integrin engagement
extracellularly leads to recruitment of multimolecular com-
plexes (blue molecules) involved in intracellular signalling
pathways controlling various cellular functions as listed. ECM,
extracellular matrix; FAK, focal adhesion kinase; MEK, mitogen
activated protein kinase kinase; ERK, extracellular signal-
regulated kinase; Src, proto-oncogenic tyrosine kinases; Cas, a
family of proteins related to the actin cytoskeleton. Diagram
adapted from (Berrier and Yamada, 2007).interaction with membrane bound proteins such as vascular-
or intracellular- cell adhesion molecules (VCAM and ICAM)
(Humphries et al., 2006; Docheva et al., 2007; Fisher et al.,
2001) or through linker molecules such as von Willebrand
factor, which assists in the binding of platelets to one another
during blood clotting (Bennett et al., 2009) (Table 1, Fig. 1).
Outside-in signalling of integrin receptors through
interactions with the ECM generates clustering of integrin
heterodimers called focal adhesion sites. Integrin cluster-
ing occurs after ECM adhesion promoting lateral associa-
tion with other cell surface receptors and increases in the
cytoplasmic concentration of cell signalling molecules such
as PI3-kinase and MEK-ERK, which are already implicated
in hESC maintenance (Li et al., 2007; Kang et al., 2005;
Pera and Tam, 2010; Armstrong et al., 2006). The focal
adhesion sites can recruit over 50 different cytoplasmic
proteins to the integrin cytoplasmic domain (Lo, 2006).
Proteins recruited comprise of 3 general classes: 1)
integrin binding proteins (e.g. talin or focal adhesion
kinase), 2) scaffold and adaptor proteins (e.g. those of
the cytoskeleton, tensin, vinculin, paxillin and α-actinin)
and 3) enzymes that effect downstream signalling to
influence cytoskeletal remodelling, cell migration, survival
and gene regulation (e.g. tyrosine kinases, serine/threo-
nine kinases, tyrosine phosphatases) although many
recruited proteins can be categorised in more than one
class (Fig. 2) (Berrier and Yamada, 2007). No enzymatic
activity has as yet been identified in the cytoplasmic
domains of integrin receptors.
Integrin Expression During Development
Knockout mouse models have allowed examination of the
role of almost all known integrin subunits during mammalian
embryonic development (Hynes, 2002) (Table 1). Deletion or
mutation of specific integrin subunits in mice leads to a wide
range of phenotypes in the developing embryo from early
lethality to particular organ dysfunction to normal mouse
development. For a concise review of these experiments
please refer to Bouvard et al., Meighan and Schwarzbauer
5Stem cell integrins: Implications for ex-vivo culture and cellular therapiesand Bokel and Brown (Bouvard et al., 2001; Meighan and
Schwarzbauer, 2008; Bokel and Brown, 2002). Deletion of
β1, a subunit of 12 out of the 24 integrin heterodimers
(Table 1) for example leads to failure to implant due to inner
cell mass (ICM) deficiencies (Stephens et al., 1995; Fassler
and Meyer, 1995). Chimeric mice have been used to study the
effects of β1 subunit deficiencies and found effects on
multiple cell lineages, tissues and cell functions including
haematopoietic stem cell (HSC) homing and migration
(Potocnik et al., 2000; Hirsch et al., 1996), impaired
vasculogenesis in mouse embryonic stem cells (mESC)
(Bloch et al., 1997), reduced proliferation in keratinocytes
and cardiac muscle defects (Keller et al., 2001; Baudoin
et al., 1998). In addition to the effects of altering β1, here
we provide a concise summary of the effects of deleting
certain integrins during development and how differentia-
tion of cells to the three somatic lineages; Endoderm,
Mesoderm and Ectoderm are affected.
Endoderm
In mouse embryoid body models, a system using 3D clumps of
mESC, integrins are required for the differentiation of visceral
endoderm (Liu et al., 2009) and there is an interplay and
redundancy between β1 and β3 in their ability to support
differentiation of visceral endoderm. β1 ablation resulted in
endoderm detachment, reduced basement membrane pro-
duction and a malfunction of GATA-4 nuclear localisation. In
this study vitronectin substrates were able to rescue GATA-4
nuclear localisation and up regulate αVβ3 demonstrating the
importance of correct ECM constitution for this particular cell
lineage. In addition, Liu and colleagues stained for differentβ1
integrin binding partners in mouse embryos at day 6.5 showing
α5 was mainly expressed in the endoderm, α6 in the epiblast,
α2 and α3 in the trophoblast (Liu et al., 2009). Keratinocytes
are an excellent example of the requirement of an appropriate
ECM matrix as it has long been known they are induced to
terminally differentiate and halt their cell cycle in suspension
culture (Green, 1977; Levy et al., 2000). Levy et al. showed
that not only was inhibition of keratinocyte differentiation
dependant on a ligand occupied β1 receptor but also that the
signal was dependant on the number of occupied receptors and
not the proportion (Levy et al., 2000). Mice with α6 or β4
deletions have severe skin blistering and die shortly after birth
(Georges-Labouesse et al., 1996; van der Neut et al., 1996).
Intracellular signals generated from integrin associated
enzymes can be difficult to study in mouse development
given those integrins also play a major role in adherence of
cells. By generating a β4 cytoplasmic mutant, Nikolopoulos
and colleagues were able to determine this particular integrin
subunit played a major role in cell proliferation in the
epidermis while still maintaining cell attachment to the ECM
(Nikolopoulos et al., 2005). In addition, follow-on studies
showed that this pro-proliferative effect was dependant on
interaction with the epidermal growth factor receptor (Guo et
al., 2006) (Fig. 1).Mesoderm
In addition to β1 effects on migration of HSCs, migration can
also be altered by deletion or mutation of other integrinsubunits including α4 and α6 (Qian et al., 2007; Scott et al.,
2003). α4 deletion results in embryonic lethality at day 12.5
due to placental and cardiac defects (Yang et al., 1995). β7
defects impair a number of lymphocyte associated functions
including migration to lymph nodes (Wagner et al., 1998),
formation of gut associated lymphoid tissue and homing of
lymphocytes to gut associated Peyer's patches (Kunkel et al.,
1998). One of the methods of integrin association and cell-
cell adhesion already mentioned is through linker molecules
(Fig. 1). In wounded mice, the heterodimer αIIbβ3, once
activated, binds to soluble fibrinogen and catalyses the
cross-linking of platelets and blood clotting, eventually
sealing the wound (Bennett et al., 2009). Platelet aggrega-
tion and clot formation is noticeably impaired in mice with
β3 defects (Law et al., 1999).Ectoderm
Early embryonic ectoderm specification from the ICM relies on
neighbouring primitive endoderm cells laying down a base-
ment membrane that polarises ICM cells influencing differen-
tiation trajectories. This process is tied to the interplay
between laminin in the ECM and the β1 integrin subunit
(Smyth et al., 1999). Similar to effects on cell migration by
integrins in HSCs, lack of α3 has been associated with
defective neuron migration in mice (Anton et al., 1999). In
addition α6 and α7 have been associated with varying
developing tissues in the brain including cerebral cortex,
retina and peripheral nerve regeneration (Georges-Labouesse
et al., 1998; De Arcangelis et al., 1999).Integrin Expression in Human Stem Cells
Integrin expression in human embryonic stem cells and
selected adult stem cell types is summarised in Table 2. We
define here the known expression profiles of integrins on
human stem cells of four different types: embryonic,
mesenchymal, haematopoietic and neural.Human Embryonic Stem Cells
Integrin expression and function in hESC has not been
extensively studied, at least not as the major theme of the
publication. Research has been limited to detection of
integrins indirectly by doing global transcript analysis
(Assou et al., 2007; Hirst et al., 2007) or directly when
investigating cell interactions with various ECM components
(Xu et al., 2001; Miyazaki et al., 2008; Vuoristo et al., 2009),
mostly vitronectin (Braam et al., 2008; Rowland et al., 2009;
Prowse et al., 2010). These studies have detected expression
of integrins α1,2,3,5,6,7,V, 11 and E and β1,2,3 and 5 in
undifferentiated hESC yet there are contradictions within
this data (Table 2). Contradictions are due most likely to
inter-line variation or the “highly plastic phenotype” (Pera
and Tam, 2010) of embryonic stem cells. In addition, culture
methodologies (e.g. feeder layer vs. feeder free) and
methods of analysis vary significantly and may change
integrin expression [although evidence exists to the contrary
for undifferentiated hESC tested for integrin expression from
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6 A.B.J. Prowse et al.different culture backgrounds (Braam et al., 2008)] high-
lighting the importance of defined substrates and high
throughput methodologies (see below) to tailor ideal culture
conditions for individual lines.Haematopoietic Stem Cells
HSCs can be found in two places: the osteoblastic niche,
comprised of osteoblasts, fibroblasts and osteoclasts and
associated with the vasculature in the perivascular niche.
HSCs (or CD34+ Haematopoietic progenitors) express α4-6,
α7, α9, β1 and β2 (Gu et al., 2003; Schreiber et al., 2009;
Roy and Verfaillie, 1999) and through mRNA or cell surface
antibody detection certain integrin subunits have not been
able to be identified including α1-3, α8, α10 and α11
(Table 2). The primary function of integrins on HSC or CD34+
progenitors seems to be homing and migration (Bonig et al.,
2009; Grassinger et al., 2009; Lapidot et al., 2005). Given the
importance of integrins in the homing of HSC derived cell
types in the mouse and in human equivalents, promoting the
correct integrin expression in differentiated cells derived
from earlier progenitors is therefore essential for use of
those cells in therapeutic applications.Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are non-haematopoietic
stromal stem cells. MSCs can be sourced from adipose tissue,
amniotic fluid, bone marrow and fetal blood, liver and spleen
(reviewed in (Chamberlain et al., 2007)). Variation in marker
expression occurs due to tissue source, isolation methods and
tissue culture practices and complicates identifying an
integrin expression profile for MSCs. Furthermore, as with
other cell types, expansion of MSCs seems to lead to
outgrowth of more committed transit amplifying cells and
thus cultured MSCs are often termed multipotent stromal
cells rather than stem cells. Culture expanded MSCs may
show some specificity at migrating to sites of injury, but with
generally a low efficiency. It is suspected that this is due to
specific receptors and ligands expressed on the MSCs surface
and target tissue (Chamberlain et al., 2007). Human MSCs are
known to express α1-5, V and β1, 3 and 4 (Minguell et al.,
2001; Krampera et al., 2006) as well as α6, 11 and X and β2, 7
and 8 integrins (Brooke et al., 2008) (See Table 2 for full list).
This data has been obtained from a broad range of “MSCs”
types and methods of analysis (microarray, flow cytometry,
immunofluorescence) each with their own detection limits.
Variation in integrin expression between MSCs of different
origins is highlighted by recent work of Brooke et al (personal
communication) where, of the integrins tested (α1-5, 10, 11,
V and E and β1, 2 and 5), only α3, 5, 11, V and β1 were
expressed across human MSCs of three different tissue origins
(bone marrow, placental and unrestricted somatic stem
cells). Without delving into the controversies of what
constitutes an MSC (Docheva et al., 2007), the variation in
cell surface integrin expression fromMSCs of different origins
and the ability to change integrin expression in 3D matrices
highlights the importance of establishing appropriate ECMs
for the cells of choice to grow in.
7Stem cell integrins: Implications for ex-vivo culture and cellular therapiesNeural Stem Cells
In the central nervous system, neural stem cells (NSCs) are
thought to reside within a niche, surrounded by the correct
cues to maintain a correct balance between maintenance
and differentiation (Campos, 2005; Flanagan et al., 2006).
These cells then migrate from the ventricular zone along
radial glia to form the multilayered mature cortex, first as
lineage restricted progenitors and then as committed,
mature neural cells. This complicated multistep process is
heavily reliant on cues interpreted via integrins and their
interaction with the changing ECM during cell division and
migration (Campos, 2005).
Neural stem cells are difficult to identify and isolate and
cultured neurospheres are used for the majority of in vitro
studies. There have been a number of studies focused on
identifying which integrins play a role in these processes,
however the native heterodimeric makeup remains unclear.
From expression analysis, β1-class integrins predominate, and
β1 expression can be used as a cell surface marker for NSC
enrichment by FACS (Hall et al., 2006; Pruszak et al., 2009).
β1-integrin mediated signalling has been indicated in survival,
maintenance, proliferation, migration and differentiation of
NSCs (Campos, 2005). β1-integrin function is essential during
early development and is day 5 embryonic lethal in knockout
mice. It remains unclear which α-integrins partner with β1 as
expression of α2, α3, α5, α6 and α7 has been detected in NSCs
(Flanagan et al., 2006) (Table 2). However, there is some
evidence that α6β1 and its interaction with laminin plays a
crucial role in NSC biology as culturing neurospheres on laminin
enhanced cell migration, expansion and differentiation
(Flanagan et al., 2006).ECM Constitution During In Vitro Differentiation and Tools
for Integrin Investigation
In an experiment investigating differentiation of hESC
towards definitive endoderm, Wong and colleagues show
up-regulation of the vitronectin/fibronectin specific integrin
subunits αV, α5, β3, β5 and β6 and a down regulation of the
laminin specific subunits α3, α6 and β4 (Wong et al., 2010).
This work suggests there may be a requirement to alter ECM
constitution in order to effectively differentiate hESC
towards the intended lineage and mature adult cell
phenotype, in this case definitive endoderm. Similarly, the
oligodendrocyte progenitor cells produced by Geron from
human embryonic stem cells for phase I clinical trials for
treatment of acute spinal cord injury (Briefing, 2010) were
grown on Matrigel for much of the differentiation process
before transfer to laminin for terminal differentiation (Nistor
et al., 2005; Keirstead et al., 2005). In another example, van
Laake and colleagues have shown changes in integrin
expression in hESC during differentiation to cardiomyocytes
in mouse transplantation experiments (van Laake et al.,
2010). Here, changes in the expression of different integrin
receptors for laminin were observed (α3 up regulated and α6
down regulated) during in vivo maturation of hESC derived
cardiomyocytes indicating different laminin isotypes may
play a role while the fibronectin/vitronectin specific
subunits αV and α5 were down regulated. Pruszak et al.
have similarly shown changes in integrin expression duringdifferent stages of neural precursor differentiation and a
down regulation of β1 (Pruszak et al., 2009). These examples
highlight that lineage specific differentiation of hESC might
be better facilitated by altering the ECM makeup to include
or exclude certain ECM molecules and develop a mature,
differentiated phenotype.
Given the evidence presented so far regarding effects of
integrin mediated cell responses, it should be apparent that
tools to investigate cell-ECM interactions are paramount for the
use of hESC and adult stem cell types in clinical applications.
Tools for defining ECM matrices in vitro are of critical
importance given that it has been shown certain cell types
only express some integrins in tissue culture environments. For
example α5β1, a fibronectin receptor is only expressed in
keratinocytes in vivo during disease phenotypes or wound
healing and this is an expression also observed in vitro due likely
to stress of the tissue culture environment (Watt, 2002).Fusion and recombinant protein production
Our ability to produce recombinant proteins from cell culture
has facilitated the production of large amounts of pure ECM
proteins, unlike more traditional methods of extraction from
animal tissues. Even high molecular weight, complex ECM
molecules such as laminin (comprised of 3 subunits, totalling
between 400-900 kDa for each of the isomers known
(Aumailley et al., 2005)) can now be readily and easily
synthesised in quantities required for hESC culture and scale-
up (Miyazaki et al., 2008). A number of labs have used
recombinant laminin 511 as a matrix for hESC support over
long-term culture and it is now also commercially available
(Miyazaki et al., 2008; Rodin et al., 2010). Similarly, full
length (Braam et al., 2008) or fragments (Prowse et al.,
2010) of vitronectin have been used as well as fragments of
the binding domains of laminin and fibronectin (Melkoumian
et al., 2010). Chimeric, recombinantly produced proteins
also offer an advantage by being able to systematically
activate 2 or more pathways with the addition of only a single
polypeptide. For example, Manton and colleagues (Manton
et al., 2010) have fused two proteins involved in hESC
support, vitronectin (Braam et al., 2008) and IGF1 (Wang
et al., 2007) into a complex that co-activates two separate
receptors (IGF-1R and the integrin dimer αVβ5, (Van
Lonkhuyzen et al., 2007)). Given the cross-talk between
integrin and growth factor receptors (Comoglio et al., 2003)
(Fig. 1) there is a diverse range of ECM/growth factor fusion
proteins that could be developed for the maintenance and
differentiation of embryonic and adult stem cells alike. The
vitronectin/IGF-1 fusion was also of particular use as it was
functional as a soluble protein (Manton et al., 2010) and not
physically linked to the surface meaning different ECM/
growth factor chimeric proteins could be added at different
time points of a differentiation process subverting the need
to change the cells from one ECM surface to another and risk
cell loss due to anoikis (Wang et al., 2009).Defined Substrates
Several recent publications have highlighted that a fully
defined ECM (whether synthetic or natural) can support and
8 A.B.J. Prowse et al.maintain hESC equivalent to current mixed ECM controls
from mouse tumour extracts (Rodin et al., 2010; Melkoumian
et al., 2010; Villa-Diaz et al., 2010) however, none of these
studies attempt to investigate the signalling networks
activated through such ECMs. Recent work by George et al.
has used defined surfaces that can be functionalised with
known ECM fragments capable of supporting hESC growth
that will prevent any deposition of ECM by hESC or from
serum containing media ensuring the surface originally
manufactured is the surface supporting the cells (George
et al., 2009). In addition this can be done so in a spatially
orientated manner to define the concentration of ligand
observed by the cells. Deposition of an ECM in a spatially
regulated manner has been shown to affect neuronal
migration in 3-dimensions (Kapur and Shoichet, 2003) and
bone marrow cell spreading (Mapili et al., 2005). A non-
fouling, functionalised surface with spatially designed
“islands of protein” such as these could be used as an
appropriate tool to investigate the cell signalling initiated
through individual ECM molecules. Given that in vivo, no ECM
is composed of only one protein it is highly unlikely that an
artificial 2D or 3D environment composed of a single
attachment factor will be sufficient in supporting the cell
type of interest. Thus stoichiometry of different ECM
molecules, factorial analyses, high throughput arrays and
small molecule screening (Flaim et al., 2005; Flaim et al.,
2008; Anderson et al., 2004; LaBarge et al., 2009) will be the
key to appropriately defining an ECM surface for hESC
growth, maintenance and differentiation as well as investi-
gating intracellular signalling cascades initiated by outside-
in signalling.2D vs. 3D
Replicating the 3D niche is difficult and requires consider-
ation of scaffold rigidity, matrix deposition, and cell
migration into the scaffold but techniques to overcome
these challenges are becoming a reality (Griffith and Swartz,
2006). There is a significant body of knowledge on 3D culture
of numerous cell types and the changes that occur in 2D vs.
3D. For example, addition of signals from collagen or
fibronectin to the dorsal surface of fibroblasts on a 2D
surface quickly bi-polarises the integrin expression profile
giving the cells a morphology characteristic of 3D environ-
ments (Beningo et al., 2004). With regards to MSCs,
variations in integrin expression occur when cells are grown
in 3D and changes occur to differentiation trajectories when
compared to 2D flat bed environments where only the
ventral side of cells contacts the ECM (Martino et al., 2009;
Wozniak et al., 2004; Potapova et al., 2008). In addition, 3D
environments can have altered effects on cell migration
(Even-Ram and Yamada, 2005), drug response (Sivaraman
et al., 2005), intracellular signalling and more (Griffith and
Swartz, 2006). Technologies available to study the effects of
a 3D environment include encapsulation in hydrogels
functionalised with different ECM proteins to enhance
differentiation (Hwang et al., 2006; Ferreira et al., 2007),
High throughput systems for investigation of 3D clusters of
stem cells (Fernandes et al., 2010; Timmins et al., 2004) and
a wide variety of microcarriers (Oh et al., 2009; Lock and
Tzanakakis, 2009; Fernandes et al., 2009), whose results mayhave more biological relevance into cell behaviour during
differentiation therefore enhancing investigation into integ-
rin expression and signalling.Conclusion/Future Directions
Integrin expression impacts on a wide range of cellular
responses in the key areas of cell survival, differentiation,
migration and adhesion. The varied integrin expression
displayed by stem cells of different tissue origins and the
importance of integrin mediated signalling and adhesion
during development highlight the need to better understand
the signalling mechanisms involved. High-throughput
screens, defined surfaces and recombinant protein technol-
ogy are just some of the options available for investigating
integrin related cell-ECM interactions and cell responses.
These technologies will allow the definition of ideal culture
environments to direct and maintain differentiation of cells
to produce mature, functional cells suitable for clinical
applications. HESC and adult stem cells are complex systems
often with varied responses between cell lines to the same
stimuli. Advancing technologies for cell-ECM interactions will
allow tailoring of tissue culture environments specific for
individual cell lines and ultimately our ability to replicate in
vivo conditions will lead to enhanced production of cells
disease treatment.Acknowledgments
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